- increased monocyte cell number / IMPC
- abnormal cranium morphology / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- fusion of vertebral arches / IMPC
- decreased eosinophil cell number / IMPC
- decreased circulating amylase level / IMPC
- preweaning lethality, complete penetrance / IMPC
- increased Ly6C low monocyte number / IMPC
C57BL/6N-Wactm2b(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:14212 |
International strain name | C57BL/6N-Wactm2b(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | MEPD0997_2_D04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Wactm2b(EUCOMM)Wtsi |
Gene/Transgene symbol | Wac |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone MEPD0997_2_D04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation / Orphanet_466950
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased eosinophil cell number / IMPC
- increased Ly6C low monocyte number / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal cranium morphology / IMPC
- decreased circulating triglyceride level / IMPC
- fusion of vertebral arches / IMPC
- preweaning lethality, complete penetrance / IMPC
- decreased circulating amylase level / IMPC
- increased monocyte cell number / IMPC
- increased mean platelet volume / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).